2-DG (2-Deoxy-D-glucose): Selectivity & Specificity

2-DG (2-Deoxy-D-glucose) is a potent inhibitor of WNV (500 mg/kg), cellular ATP (10 mM), WNV-induced neuroinflammation (500 mg/kg), immune cells (500 mg/kg), Isg15 (500 mg/kg), Usp18 (500 mg/kg), Mx2 (500 mg/kg), interleukins signaling (500 mg/kg), CCL2 (500 mg/kg), CXCL10 (500 mg/kg), CXCL11 (500 mg/kg), TNF-α (500 mg/kg), HK, GLUT, HK2, HIF-1α, AMPK, GPI, glycolytic pathway, glycolysis, glucose metabolism, ATP production, ROS, Beclina-1, Atg-3, FRAP, mitochondrial complex I, mitochondrial complex IV, CAT, SOD, viral synthesis, protein energy production, glycosylation, mTOR, TSC1, SARS-CoV-2, N-glycosylation, UPR pathway, viral replication, glycosylation of viral proteins, inflammatory responses, hyperglycolysis, metabolic reprograming, CD8+ T cell-mediated cytotoxicity, IFN-g production, MHCII, CD86, TNFα production, WNV multiplication, GLUT1, cellular viability, clonogenic survival, apoptotic cell, angiogenesis, cell viability, proliferation, N-linked glycosylation, cell proliferation, IL-1B, aerobic glycolysis, PI3K signaling, mTOR signaling, GLUTs, cellular ATP production, Akt phosphorylation, endoplasmic reticulum stress, autophagy, tumor burden, tumor growth, oxygen consumption rate, mitochondrial content, PDH, LDH, mTORC1, S6K1, ACC, AMPK phosphorylation, mTORC1-mediated promotion of glycolysis, ERK phosphorylation, PI3K/AKT, ATP-dependent drug efflux transporters. 2-DG (2-Deoxy-D-glucose) exhibits the greatest inhibitory potency toward cellular ATP (IC50 = 10000000 nM).